Jan 25(Reuters) - Anhui Anke Biotechnology Group Co Ltd
* Says co plans to acquire approval for clinical trial and technique of a kind of monoclonal antibody injection from Jiangsu Aosaikang Pharmaceutical Co Ltd (seller), at the price of 50 million yuan
* Say co also needs to pay sales commissions to seller
Source text in Chinese: goo.gl/m4pD9h
Further company coverage: (Beijing Headline News)
 